Get the Stockscreener App
2.47
0.82%
0.02
After Hours:
2.55
0.08
+3.24%
Edesa Biotech Inc stock is traded at $2.47, with a volume of 1.23M.
It is up +0.82% in the last 24 hours and up +6.47% over the past month.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
See More
Previous Close:
$2.45
Open:
$2.38
24h Volume:
1.23M
Relative Volume:
29.48
Market Cap:
$17.38M
Revenue:
-
Net Income/Loss:
$-7.72M
P/E Ratio:
-0.9358
EPS:
-2.6394
Net Cash Flow:
$-6.25M
1W Performance:
+3.78%
1M Performance:
+6.47%
6M Performance:
+1.23%
1Y Performance:
-44.49%
1-Day Range:
$2.38
$2.48
1-Week Range:
$2.36
$2.50
52-Week Range:
$1.55
$5.00
Edesa Biotech Inc Stock (EDSA) Company Profile
Name
Edesa Biotech Inc
Sector
Industry
Phone
(905) 475-1234
Address
100 SPY COURT, MARKHAM, ON
Compare EDSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
2.47 | 17.99M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Edesa Biotech Inc Stock (EDSA) Latest News
Will Edesa Biotech Inc. stock maintain growth storyEarnings Beat & Technical Pattern Alert System - newser.com
Future of United States Contact Dermatitis Treatment Market | - openPR.com
Volume spikes in Edesa Biotech Inc. stock – what they meanJuly 2025 Outlook & Weekly Return Optimization Alerts - newser.com
Tools to assess Edesa Biotech Inc.’s risk profileStop Loss & Free Weekly Watchlist of Top Performers - newser.com
Is Edesa Biotech Inc. stock resilient to inflation2025 Major Catalysts & Safe Capital Growth Plans - newser.com
Critical Comparison: Sana Biotechnology (NASDAQ:SANA) & Edesa Biotech (NASDAQ:EDSA) - Defense World
What candlestick patterns are forming on Edesa Biotech Inc.Earnings Performance Report & AI Powered Market Entry Strategies - newser.com
Does Edesa Biotech Inc. fit your quant trading modelEarnings Overview Summary & Advanced Technical Signal Analysis - newser.com
Sentiment analysis tools applied to Edesa Biotech Inc.July 2025 Big Picture & High Accuracy Trade Signal Alerts - newser.com
How to use a screener to detect Edesa Biotech Inc. breakoutsEarnings Growth Report & Expert Verified Movement Alerts - newser.com
What drives Edesa Biotech Inc stock priceMid Cap Growth Trends & Build Wealth Brick by Brick With Us - earlytimes.in
Edesa Biotech (NASDAQ:EDSA) Trading Down 0.8% – Time to Sell? - Defense World
Edesa Biotech Inc. stock trend forecast2025 Investor Takeaways & Community Consensus Picks - newser.com
Real time scanner hits for Edesa Biotech Inc. explainedQuarterly Trade Report & Low Risk Entry Point Guides - newser.com
Chipmakers Recap: Can Edesa Biotech Inc be the next market leaderJuly 2025 Price Swings & Precise Buy Zone Identification - خودرو بانک
Bull Run: Is Edesa Biotech Inc. stock risky to hold now2025 Winners & Losers & Low Risk High Win Rate Picks - khodrobank.com
EPS Watch: Is Edesa Biotech Inc. undervalued by DCF analysisIPO Watch & High Return Trade Guides - خودرو بانک
Visualizing Edesa Biotech Inc. stock with heatmapsEarnings Recap Report & Low Drawdown Investment Ideas - newser.com
Moving Averages: Does Edesa Biotech Inc have pricing power2025 Geopolitical Influence & Technical Entry and Exit Tips - خودرو بانک
Backtesting results for Edesa Biotech Inc. trading strategies2025 Key Highlights & AI Enhanced Trading Signals - newser.com
Does Edesa Biotech Inc. show high probability of reboundEarnings Risk Summary & Fast Entry High Yield Tips - newser.com
Key metrics from Edesa Biotech Inc.’s quarterly dataWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
What MACD and RSI say about Edesa Biotech Inc.July 2025 Volume & Daily Entry Point Alerts - newser.com
Real time pattern detection on Edesa Biotech Inc. stockGlobal Markets & Real-Time Stock Entry Alerts - newser.com
Portfolio Shifts: Does Edesa Biotech Inc have pricing powerStop Loss & AI Powered Buy and Sell Recommendations - خودرو بانک
Aug Rallies: Will Edesa Biotech Inc. announce a stock splitQuarterly Portfolio Summary & High Accuracy Investment Entry Signals - khodrobank.com
Investment Recap: Is Immuron Limited Depositary Receipt stock good for income investors2025 Geopolitical Influence & Safe Entry Point Identification - khodrobank.com
How to integrate Edesa Biotech Inc. into portfolio analysis toolsGlobal Markets & Fast Gain Stock Tips - newser.com
Aug Closing: Is Edesa Biotech Inc. part of any major indexStop Loss & Smart Allocation Stock Tips - khodrobank.com
Edesa Biotech Inc Stock (EDSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):